/C O R R E C T I O N from Source -- Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions/
In the news release, IIROC Trading Halt - PSQ.P, issued 25-Jun-2019 by Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions over CNW, we are advised by the company that the reason code for the Halt should be "Failure to Complete a Qualifying Transaction within 24 Months Of Listing" only and the Halt Time should be 8:00 AM. The complete, corrected release follows:
IIROC Trading Halt - PSQ.P
VANCOUVER, June 25, 2019 /CNW/ - The following issues have been halted by IIROC:
Company: P Squared Renewables Inc.
TSX-Venture Symbol: PSQ.P (All Issues)
Reason: Failure to Complete a Qualifying Transaction within 24 Months Of Listing
Halt Time (ET): 8:00 AM
IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...